Videos

Standardized, patient-completed screening for substance use at delivery admissions reduced racial disparities in urine toxicology testing while improving testing efficiency, according a study from Mariam Naqvi, MD, and colleagues.

An expert infectious disease panel discusses how recent federal vaccine schedule changes can impact maternal immunizations and potential repercussions.

An expert infectious disease panel discusses how recent federal vaccine schedule changes can impact maternal immunizations and potential repercussions.

Dardik explains how De Novo-cleared AI identifies preterm birth risk in low-risk pregnancies through whole-image analysis.

In a 29-state review of 2017–2019 data, 86.4% of pregnancy-related infection deaths were deemed preventable, with genital tract infections, group A streptococcus, and delays in antibiotics emerging as key targets for intervention.

Kevin Benson highlighted that the TITAN 2 study demonstrates the Altaviva ITNM system as a safe, minimally invasive, and durable solution for real-world patients who have failed prior overactive bladder treatments.

Raquel Dardik explains how the FDA-cleared Delivery Date AI uses unbiased image analysis to provide a precise predicted delivery date without disrupting existing clinical workflows.

Sean Raj, MD, MBA, emphasizes that ob-gyns are uniquely positioned to improve cardiovascular outcomes by integrating risk assessments and imaging-based screenings into routine women's health visits.

Genevieve Neal-Perry, MD, PhD, outlines unmet needs in managing vasomotor symptoms among African American women and discusses how elinzanetant (Lynkuet) may help shape more equitable care.

A Finnish registry study indicates that women with endometriosis have a 51% higher risk of miscarriage and a 2-fold increased risk of ectopic pregnancy compared to controls.

Sasha Vereecken explains the potential quality of life and sexual worry benefits of investigational ACT for stress urinary incontinence, as well as who may be best suited for the implant.

Very early home pregnancy testing modestly advances detection but substantially increases false negatives and detection of very early pregnancy losses, according to a recent study.

A large-scale TriNetX database analysis found no statistically significant difference in the incidence of vulvar atrophy or hypertrophy between non-diabetic women using GLP-1RAs and those who were not.

Sasha Vereecken explains how ACT improved continence and reduced sexual worry in women with SUI, with pad use and sexual scores showing significant, durable improvement.

Study author Oskari Heikinheimo explains how patients should approach earlier surveillance, fertility options, and pregnancy considerations and risks for women with endometriosis.

In this video interview from SMFM 2026, Alexandra Hammerquist, MD, explains how an AI-based model achieved accurate and sensitive PAS prediction before delivery.

Genevieve Neal-Perry, MD, PhD, discusses how elinzanetant (Lynkuet) improves sleep quality and menopause-related quality of life through its dual neurokinin receptor antagonism.

Genevieve Neal-Perry, MD, PhD, explains how rapid onset of symptom relief with elinzanetant (Lynkuet) may improve patient satisfaction and adherence.

“ACOG has been in the business of maternal immunization guidelines for about 15 years. It’s nice to have all those maternal immunization guidelines in one place," said Kevin Ault, MD.

A Finnish registry study found that individuals with endometriosis have significantly higher risks of miscarriage and ectopic pregnancy and a lower lifetime incidence of pregnancy.

Lori Werner emphasized that marketing today is less about advertising and more about visibility and credibility.

An institution-wide policy allowing elective induction at 39 weeks was linked to lower cesarean delivery and NICU admission rates.

The findings underscore the need for more rigorous and diverse clinical studies evaluating digital interventions.

Outdated FDA labeling, insurance uncertainty, and lack of clinic workflows are some barriers Jennifer Karlin, MD, PhD, and colleagues found for user-administered injectable contraceptives.

The COEQUaL initiative seeks to reduce racial disparities in uterine fibroid care by promoting earlier diagnosis, equitable treatment discussions, and values-congruent, patient-centered decision-making.

Speaking at the SMFM 2026 Pregnancy Meeting, Molina emphasized that HIPAA protections, clear policies, and staff training are central to equitable ob-gyn care for immigrant patients.

A new analysis finds that most pregnant patients with depression or anxiety discontinue SSRIs/SNRIs—and face nearly double the risk of mental health emergencies.

Speaking at SMFM 2026, Rose Molina, MD, MPH, FACOG, urged ob-gyns to adopt immigration-informed care to protect access, safety, and trust for immigrant patients.

Christina Paidas Teefey, MD, says advances in early prenatal diagnosis are accelerating fetal center referrals and underscoring the need for multidisciplinary and psychosocial support.

According to Aleece Fosnight, MSPAS, PA-C, the physiologic effects of hypothyroidism can directly affect neuromuscular coordination, bladder emptying, and pelvic floor function.